Donor-Derived Myeloid Heme Oxygenase-1 Controls the Development of Graft-Versus-Host Disease

Graft-versus-host disease (GVHD) remains a major clinical drawback of allogeneic hematopoietic stem cell transplantation (HSCT). Here, we investigated how the stress responsive heme catabolizing enzyme heme oxygenase-1 (HO-1, encoded by HMOX1) regulates GVHD in response to allogeneic hematopoietic s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Immunol
Autors principals: Spilleboudt, Chloé, De Wilde, Virginie, Lewalle, Philippe, Cabanne, Ludovic, Leclerc, Mathieu, Beckerich, Florence, Bories, Dominique, Cardoso, Silvia, Soares, Miguel P., Vokaer, Benoît, Hougardy, Jean-Michel, Flamand, Véronique, Racapé, Judith, Abramowicz, Marc, Maury, Sébastien, Le Moine, Alain
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7849683/
https://ncbi.nlm.nih.gov/pubmed/33537027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.579151
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars